Categories: News

Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences

ALHAMBRA, Calif., May 11, 2021 /PRNewswire/ — Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced that Brandon Sim, Chief Operating Officer and Chief Technology Officer, and Eric Chin, Chief Financial Officer, are scheduled to present at the following virtual investor events.

RBC Global Healthcare Conference
Tuesday, May 18, 2021, at 12:05 p.m. PT/3:05 p.m. ET
Webcast link: https://event.on24.com/wcc/r/3173736/DDE03AE965E0DCC8CAC30A5EC5BFD21E

UBS Global Healthcare Conference
Tuesday, May 25, 2021, at 10 a.m. PT/1 p.m. ET
Webcast link: https://event.webcasts.com/starthere.jsp?ei=1458101&tp_key=ee68a5a3c2

Management will also be participating in one-on-one virtual meetings during these events.

Following the live webcasts, a recording of the Company’s presentations will be made available at the Investors section of the Company’s website at www.apollomed.net. Those interested in meeting with management at either conference may contact ApolloMed’s Investor Relations representatives listed below.

About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed’s subsidiaries include management services organizations (“MSOs”), affiliated independent practice associations (“IPAs”) and a Next Generation Accountable Care Organization (“NGACO”). Network Medical Management, Inc. and Apollo Medical Management, Inc. are the administrative and managerial services companies for the affiliated physician owned professional corporations that contract with independent physicians to deliver medical services in-office and virtually under the Allied Pacific of California IPA, Alpha Care Medical Group, Inc. and Accountable Health Care IPA brands. These affiliates are supported by ApolloMed Hospitalists, a Medical Corporation. Our NGACO operates under the APA ACO, Inc. brand and participates in the Centers for Medicare & Medicaid Services program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program’s attribution-based risk sharing model. For more information, please visit www.apollomed.net.

FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@apollomed.net

Carolyne Sohn, The Equity Group
(415) 568-2255
csohn@equityny.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-to-present-at-upcoming-investor-conferences-301288176.html

SOURCE Apollo Medical Holdings, Inc.

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

2 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

5 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

5 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

5 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

5 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

5 hours ago